Cerebral Small Vessels Disease Recruiting Phase 2 Trials for Exenatide (DB01276)
Also known as: Cerebral Small-vessel Disease / Cerebral Small Vessel Disease / Cerebral Small Vessel Diseases / Cerebral microangiopathy / Small vessel cerebrovascular disease (disorder) / Cerebral small vessel ischaemic disease / Cerebral small vessel ischemic disease
Indication | Status | Phase |
---|---|---|
DBCOND0072196 (Cerebral Small Vessels Disease) | Recruiting | 2 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT05356104 | GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD) | Treatment |